• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类凝血酶生成和蛋白C活化指标与衰老相关的变化。规范衰老研究。

Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

作者信息

Bauer K A, Weiss L M, Sparrow D, Vokonas P S, Rosenberg R D

机构信息

Charles A. Dana Research Institute, Boston, Massachusetts.

出版信息

J Clin Invest. 1987 Dec;80(6):1527-34. doi: 10.1172/JCI113238.

DOI:10.1172/JCI113238
PMID:2824564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC442420/
Abstract

In view of the known association of vascular disease with increasing age, we have conducted an analysis of hemostatic system activity with respect to perturbations induced by aging phenomena. We have utilized an immunochemical assay for prothrombin fragment F1 + 2 to quantify Factor Xa activity upon prothrombin in the plasma of 199 healthy males between the ages of 42 and 80. The levels of F1 + 2 in this population generally increased as a function of age (P less than 0.0001). The metabolic behavior of this marker was determined in 10 individuals greater than 65 yr of age with varying levels of F1 + 2, which ranged from 1.28 to 5.85 nM. The elevations in the concentration of this component were not due to diminished clearance of the fragment. Radio-immunoassays for fibrinopeptide A (FPA) and the protein C activation peptide (PCP) were subsequently employed to measure thrombin activity upon fibrinogen and thrombin-thrombomodulin activity upon protein C, respectively, in 82 members of this population ranging in age from 42 to 80. Significant positive correlations were again observed between increasing age and the level of F1 + 2 (P less than 0.0001) as well as FPA (P less than 0.01) and PCP (P less than 0.002). The results of this cross-sectional study indicate that many apparently normal males of increasing age with normal immunologic levels of antithrombin III and protein C exhibit a biochemical defect that denotes the presence of an acquired prethrombotic state.

摘要

鉴于血管疾病与年龄增长之间已知的关联,我们针对衰老现象引起的扰动,对止血系统活性进行了分析。我们利用免疫化学分析法检测凝血酶原片段F1 + 2,以量化199名年龄在42至80岁之间的健康男性血浆中凝血酶原上的因子Xa活性。该人群中F1 + 2的水平通常随年龄增长而升高(P小于0.0001)。在10名年龄大于65岁、F1 + 2水平各异(范围为1.28至5.85 nM)的个体中,测定了该标志物的代谢行为。该成分浓度的升高并非由于片段清除率降低所致。随后,我们采用纤维蛋白肽A(FPA)和蛋白C活化肽(PCP)的放射免疫分析法,分别测定了该人群中82名年龄在42至80岁之间的个体中纤维蛋白原上的凝血酶活性以及蛋白C上的凝血酶 - 血栓调节蛋白活性。年龄增长与F1 + 2水平(P小于0.0001)、FPA水平(P小于0.01)和PCP水平(P小于0.002)之间再次观察到显著的正相关。这项横断面研究的结果表明,许多年龄不断增长、抗凝血酶III和蛋白C免疫水平正常的明显健康男性表现出一种生化缺陷,这表明存在一种后天性血栓前状态。

相似文献

1
Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.人类凝血酶生成和蛋白C活化指标与衰老相关的变化。规范衰老研究。
J Clin Invest. 1987 Dec;80(6):1527-34. doi: 10.1172/JCI113238.
2
Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.衰老对止血系统活性的影响:80名年龄在20至94岁之间的健康受试者的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及D-二聚体
Nouv Rev Fr Hematol (1978). 1992;34(1):43-6.
3
The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation.人类血栓前状态的病理生理学:利用止血系统激活标志物的研究所获见解。
Blood. 1987 Aug;70(2):343-50.
4
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.血浆蛋白氧化与促凝血标志物增加有关,这会导致健康受试者体内促凝血和抗凝血途径失衡。
Thromb Haemost. 2002 Jan;87(1):58-67.
5
Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.体外自凝全血中的凝血酶原片段1+2、凝血酶-抗凝血酶III复合物及纤维蛋白肽A。添加肝素及抗凝血酶III缺乏的影响。
Thromb Haemost. 1994 Jan;71(1):49-53.
6
Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.遗传性蛋白C缺乏症患者血液中的止血酶生成
Blood. 1988 May;71(5):1418-26.
7
[Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].[颅内出血与止血。通过测定和随访凝血激活产物对颅内出血患者进行监测]
Infusionsther Transfusionsmed. 1994 Aug;21(4):244-50.
8
Nonvalvular atrial fibrillation: evidence for a prothrombotic state.非瓣膜性心房颤动:血栓前状态的证据。
CMAJ. 1997 Sep 15;157(6):673-81.
9
Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.口服抗凝剂对血栓形成素质患者血液中止血系统激活的抑制作用。
J Clin Invest. 1987 Dec;80(6):1535-44. doi: 10.1172/JCI113239.
10
Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.在患有抗磷脂蛋白抗体的系统性红斑狼疮患者中,微血管损伤后体外测量的凝血酶生成增加。
Thromb Haemost. 1997 Oct;78(4):1173-7.

引用本文的文献

1
Analysis of risk factors and prediction model construction of deep vein thrombosis in patients with lumbar degenerative diseases before surgery.腰椎退变性疾病患者术前深静脉血栓形成的危险因素分析及预测模型构建
Sci Rep. 2025 Jul 18;15(1):26069. doi: 10.1038/s41598-025-10752-1.
2
Triphasic Changes in Ischemic Stroke Incidence With Age in Non-Valvular Atrial Fibrillation Patients - Pooled Analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry.非瓣膜性心房颤动患者缺血性卒中发病率随年龄的三相变化——来自信金数据库、日本心律注册研究及伏见心房颤动注册研究的汇总分析
Circ Rep. 2025 Mar 11;7(4):303-307. doi: 10.1253/circrep.CR-25-0009. eCollection 2025 Apr 10.
3
Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond.生物衰老与静脉血栓栓塞:端粒及其他相关研究综述
Biomedicines. 2024 Dec 25;13(1):15. doi: 10.3390/biomedicines13010015.
4
Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update.衰老在静脉血栓栓塞症中的病理生理学:更新。
Medicina (Kaunas). 2022 Aug 10;58(8):1078. doi: 10.3390/medicina58081078.
5
Venous thromboembolic and hemorrhagic events after meningioma surgery: A single-center retrospective cohort study of risk factors.脑膜瘤手术后的静脉血栓栓塞和出血事件:一项单中心回顾性队列研究的危险因素。
PLoS One. 2022 Aug 16;17(8):e0273189. doi: 10.1371/journal.pone.0273189. eCollection 2022.
6
Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine.凝血酶生成分析是血液凝固分析中的多功能工具:综述技术特点及从研究到实验室常规的应用。
J Thromb Haemost. 2021 Dec;19(12):2907-2917. doi: 10.1111/jth.15529. Epub 2021 Sep 26.
7
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.Xa 因子抑制在心血管预防中的多效作用:机制见解及其对抗血栓治疗的影响。
Cardiovasc Res. 2021 Jul 27;117(9):2030-2044. doi: 10.1093/cvr/cvaa263.
8
Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation.在日本房颤患者中,将其血浆浓度与固有激活凝血因子 X 活性相关联的阿哌沙班群体药代动力学和药效学。
AAPS J. 2019 Jun 24;21(5):80. doi: 10.1208/s12248-019-0353-7.
9
Role of TRPC6 in Progression of Diabetic Kidney Disease.TRPC6 在糖尿病肾病进展中的作用。
Curr Hypertens Rep. 2019 May 21;21(7):48. doi: 10.1007/s11906-019-0960-9.
10
Endovascular mechanical recanalization of acute ischaemic stroke in octogenarians.八旬老人急性缺血性卒中的血管内机械再通治疗
Eur Radiol. 2016 Jun;26(6):1742-50. doi: 10.1007/s00330-015-3969-8. Epub 2015 Sep 15.

本文引用的文献

1
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.高比放射性碘-131标记人生长激素的制备
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
2
The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.口服抗凝治疗患者血浆中凝血酶原转化的抑制剂。
Thromb Haemost. 1981 Jun 30;45(3):237-41.
3
Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.利用针对F2/F1 + 2片段和凝血酶-抗凝血酶复合物的放射免疫测定法对凝血酶原激活途径进行的研究。
Blood. 1982 May;59(5):1086-97.
4
Antithrombin III deficiency and thromboembolism.抗凝血酶III缺乏与血栓栓塞
Clin Haematol. 1981 Jun;10(2):369-90.
5
Studies with 131I-labelled antithrombin III in dogs.用¹³¹I标记抗凝血酶III对狗进行的研究。
Thromb Res. 1980 Nov 15;20(4):375-89. doi: 10.1016/0049-3848(80)90277-7.
6
Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.通过与内皮细胞结合的类肝素分子加速大鼠后肢凝血酶 - 抗凝血酶复合物的形成。
J Clin Invest. 1984 Aug;74(2):341-50. doi: 10.1172/JCI111429.
7
Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.抗凝血酶“芝加哥”:一种功能异常且肝素亲和力增加的分子,可导致家族性血栓形成倾向。
Blood. 1983 Dec;62(6):1242-50.
8
Detection of protein C activation in humans.人类中蛋白C活化的检测。
J Clin Invest. 1984 Dec;74(6):2033-41. doi: 10.1172/JCI111626.
9
Enhanced in vivo platelet "release reaction" in old healthy individuals.健康老年人体内血小板“释放反应”增强。
Thromb Res. 1980;17(3-4):329-36. doi: 10.1016/0049-3848(80)90067-5.
10
Microvascular heparin-like species with anticoagulant activity.具有抗凝活性的微血管类肝素物质。
Am J Physiol. 1983 Nov;245(5 Pt 1):H725-33. doi: 10.1152/ajpheart.1983.245.5.H725.